Storys zum Thema Economy

Folgen
Keine Story zum Thema Economy mehr verpassen.
Filtern
  • 18.04.2022 – 14:35

    Mindtree

    Mindtree Reports Strong Q4 and Full Year Performance in FY22

    Bangalore, India and Warren, N.J. (ots/PRNewswire) - Sequential revenue growth of 5.2% in constant currency; Full year revenue up 31.1%; Decade-high full year EBITDA and PAT margins; Announces highest-ever full year dividend Mindtree, a global technology services and digital transformation company, announced its consolidated results today for the fourth quarter ended March 31, 2022, as approved by its Board of directors. ...

  • 18.04.2022 – 13:43

    XTX Markets

    /DISREGARD RELEASE: XTX Markets/

    London (ots/PRNewswire) - We are advised by XTX Markets that journalists and other readers should disregard the news release, XTX Markets one of the first companies to remove employees' household carbon emissions, issued 18-Apr-2022 over PR Newswire. [User Fills Optional Text Detailing Reason for Kill] Contact: Tim Moxon - Global Head of Marketing/Communications, +44 203 198 3300, ...

  • 18.04.2022 – 13:23

    XTX Markets

    XTX Markets one of the first companies to remove employees' household carbon emissions

    London (ots/PRNewswire) - XTX Markets is one of the first companies to introduce a carbon removal programme for employees as part of its newly released climate pledges. To meet the IPPC's 1.5C scenario, the emerging consensus is that carbon capture and storage (CCS) needs to increase from around 40 million tonnes of CO2 in 2020 to 1 billion tonnes in 2030, then 10 ...

  • 14.04.2022 – 07:00

    TauRx Pharmaceuticals Ltd

    TauRx's late-stage clinical trial reaches new milestone

    Aberdeen, Scotland and Singapore (ots/PRNewswire) - - Significant milestone in the only late-stage clinical trial targeting tau pathology of Alzheimer's - TauRx on track to announce top line results in May - Trial aims to confirm efficacy of first tau-based treatment for Alzheimer's TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer's Disease (AD) research, has announced that the last patient has completed ...